Which has higher valuation & earnings, PACS or SHC?

PACS Group has higher revenue and earnings than Sotera Health. PACS Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.20 $191.54M $1.56 25.79 Sotera Health $1.16B 4.22 $77.94M $0.41 42.03

Sotera Health (SHC) Competitors

$17.23 +0.54 (+3.26%)

As of 11:42 AM Eastern

Compare

SHC vs. GH, FMS, BTSG, HIMS, and PACS

Should you buy Sotera Health stock or one of its competitors? MarketBeat compares Sotera Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sotera Health include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Sotera Health compare to Guardant Health?

Sotera Health (NASDAQ:SHC) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Sotera Health has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, meaning that its stock price is 61% more volatile than the broader market.

In the previous week, Guardant Health had 10 more articles in the media than Sotera Health. MarketBeat recorded 10 mentions for Guardant Health and 0 mentions for Sotera Health. Guardant Health's average media sentiment score of 0.09 beat Sotera Health's score of 0.00 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Sotera Health	Neutral
Guardant Health	Neutral

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sotera Health presently has a consensus price target of $20.25, indicating a potential upside of 17.50%. Guardant Health has a consensus price target of $142.19, indicating a potential upside of 0.10%. Given Sotera Health's higher probable upside, research analysts plainly believe Sotera Health is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.96

Sotera Health has a net margin of 9.91% compared to Guardant Health's net margin of -40.10%. Sotera Health's return on equity of 39.73% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Guardant Health	-40.10%	N/A	-26.42%

Sotera Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.22	$77.94M	$0.41	42.03
Guardant Health	$982.02M	19.18	-$416.28M	-$3.39	N/A

Summary

Sotera Health beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Fresenius Medical Care AG & Co. KGaA?

Sotera Health (NASDAQ:SHC) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Sotera Health has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Sotera Health. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.22	$77.94M	$0.41	42.03
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.57	$1.11B	$1.90	12.23

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Fresenius Medical Care AG & Co. KGaA had 2 more articles in the media than Sotera Health. MarketBeat recorded 2 mentions for Fresenius Medical Care AG & Co. KGaA and 0 mentions for Sotera Health. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.97 beat Sotera Health's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Overall Sentiment
Sotera Health	Neutral
Fresenius Medical Care AG & Co. KGaA	Positive

Sotera Health currently has a consensus target price of $20.25, indicating a potential upside of 17.50%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 20.49%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Sotera Health has a net margin of 9.91% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.88%. Sotera Health's return on equity of 39.73% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Summary

Sotera Health beats Fresenius Medical Care AG & Co. KGaA on 10 of the 16 factors compared between the two stocks.

How does Sotera Health compare to BrightSpring Health Services?

Sotera Health (NASDAQ:SHC) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Sotera Health has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, indicating that its share price is 87% more volatile than the broader market.

In the previous week, BrightSpring Health Services had 2 more articles in the media than Sotera Health. MarketBeat recorded 2 mentions for BrightSpring Health Services and 0 mentions for Sotera Health. BrightSpring Health Services' average media sentiment score of 0.37 beat Sotera Health's score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Overall Sentiment
Sotera Health	Neutral
BrightSpring Health Services	Neutral

91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sotera Health has a net margin of 9.91% compared to BrightSpring Health Services' net margin of 2.27%. Sotera Health's return on equity of 39.73% beat BrightSpring Health Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
BrightSpring Health Services	2.27%	14.63%	4.41%

Sotera Health presently has a consensus price target of $20.25, indicating a potential upside of 17.50%. BrightSpring Health Services has a consensus price target of $61.27, indicating a potential downside of 10.99%. Given Sotera Health's higher possible upside, equities analysts plainly believe Sotera Health is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11

BrightSpring Health Services has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.22	$77.94M	$0.41	42.03
BrightSpring Health Services	$12.91B	1.05	$190.67M	$1.41	48.82

Summary

BrightSpring Health Services beats Sotera Health on 10 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Hims & Hers Health?

Sotera Health (NASDAQ:SHC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Hims & Hers Health has higher revenue and earnings than Sotera Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.22	$77.94M	$0.41	42.03
Hims & Hers Health	$2.35B	3.05	$128.37M	-$0.09	N/A

Sotera Health has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market.

Sotera Health has a net margin of 9.91% compared to Hims & Hers Health's net margin of -0.56%. Sotera Health's return on equity of 39.73% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Hims & Hers Health	-0.56%	6.10%	1.52%

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 18 more articles in the media than Sotera Health. MarketBeat recorded 18 mentions for Hims & Hers Health and 0 mentions for Sotera Health. Hims & Hers Health's average media sentiment score of 0.80 beat Sotera Health's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Sotera Health	Neutral
Hims & Hers Health	Positive

Sotera Health currently has a consensus target price of $20.25, indicating a potential upside of 17.50%. Hims & Hers Health has a consensus target price of $29.37, indicating a potential downside of 5.06%. Given Sotera Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Sotera Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

Summary

Sotera Health beats Hims & Hers Health on 11 of the 16 factors compared between the two stocks.

How does Sotera Health compare to PACS Group?

PACS Group (NYSE:PACS) and Sotera Health (NASDAQ:SHC) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

In the previous week, PACS Group had 8 more articles in the media than Sotera Health. MarketBeat recorded 8 mentions for PACS Group and 0 mentions for Sotera Health. PACS Group's average media sentiment score of 0.44 beat Sotera Health's score of 0.00 indicating that PACS Group is being referred to more favorably in the media.

Company	Overall Sentiment
PACS Group	Neutral
Sotera Health	Neutral

91.0% of Sotera Health shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

PACS Group has higher revenue and earnings than Sotera Health. PACS Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.20	$191.54M	$1.56	25.79
Sotera Health	$1.16B	4.22	$77.94M	$0.41	42.03

PACS Group presently has a consensus price target of $48.00, suggesting a potential upside of 19.30%. Sotera Health has a consensus price target of $20.25, suggesting a potential upside of 17.50%. Given PACS Group's higher possible upside, analysts plainly believe PACS Group is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Sotera Health has a net margin of 9.91% compared to PACS Group's net margin of 4.49%. Sotera Health's return on equity of 39.73% beat PACS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Sotera Health	9.91%	39.73%	7.05%

Summary

Sotera Health beats PACS Group on 8 of the 15 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHC vs. The Competition

Export

Metric	Sotera Health	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.92B	$9.23B	$6.72B	$12.25B
Dividend Yield	N/A	1.72%	2.68%	5.89%
P/E Ratio	42.05	24.94	25.40	24.15
Price / Sales	4.22	16.77	537.13	108.48
Price / Cash	12.40	99.35	45.29	53.76
Price / Book	8.09	5.93	10.67	6.41
Net Income	$77.94M	$174.80M	$3.56B	$337.14M
7 Day Performance	8.94%	2.62%	1.72%	-0.51%
1 Month Performance	10.05%	5.00%	1.52%	1.05%
1 Year Performance	54.70%	13.68%	32.37%	29.89%

Sotera Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHC Sotera Health	3.1871 of 5 stars	$17.23 +3.3%	$20.25 +17.5%	+48.5%	$4.92B	$1.16B	42.05	3,000	Analyst Forecast
GH Guardant Health	1.6113 of 5 stars	$132.34 +1.9%	$141.95 +7.3%	+174.0%	$17.53B	$982.02M	N/A	2,506	Analyst Forecast Insider Trade
FMS Fresenius Medical Care AG & Co. KGaA	4.5209 of 5 stars	$23.72 +1.2%	$28.00 +18.0%	-14.2%	$12.82B	$22.20B	12.49	1,488	Gap Down
BTSG BrightSpring Health Services	3.9171 of 5 stars	$64.52 +0.7%	$58.53 -9.3%	+194.9%	$12.73B	$12.91B	45.75	23,500	Positive News Analyst Forecast
HIMS Hims & Hers Health	3.1369 of 5 stars	$31.75 +5.2%	$28.70 -9.6%	-24.1%	$7.36B	$2.35B	N/A	2,442	Insider Trade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHC) was last updated on 6/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sotera Health (SHC) Competitors

SHC vs. GH, FMS, BTSG, HIMS, and PACS

How does Sotera Health compare to Guardant Health?

Summary

How does Sotera Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Sotera Health compare to BrightSpring Health Services?

Summary

How does Sotera Health compare to Hims & Hers Health?

Summary

How does Sotera Health compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sotera Health (SHC) Competitors

SHC vs. GH, FMS, BTSG, HIMS, and PACS

How does Sotera Health compare to Guardant Health?

Which has more volatility and risk, SHC or GH?

Does the media favor SHC or GH?

Do insiders and institutionals believe in SHC or GH?

Do analysts recommend SHC or GH?

Is SHC or GH more profitable?

Which has preferable earnings & valuation, SHC or GH?

Summary

How does Sotera Health compare to Fresenius Medical Care AG & Co. KGaA?

Which has more volatility and risk, SHC or FMS?

Which has preferable valuation and earnings, SHC or FMS?

Do insiders & institutionals hold more shares of SHC or FMS?

Does the media prefer SHC or FMS?

Do analysts prefer SHC or FMS?

Is SHC or FMS more profitable?

Summary

How does Sotera Health compare to BrightSpring Health Services?

Which has more risk and volatility, SHC or BTSG?

Does the media favor SHC or BTSG?

Do insiders and institutionals believe in SHC or BTSG?

Is SHC or BTSG more profitable?

Do analysts recommend SHC or BTSG?

Which has better earnings and valuation, SHC or BTSG?

Summary

How does Sotera Health compare to Hims & Hers Health?

Which has better valuation & earnings, SHC or HIMS?

Which has more risk and volatility, SHC or HIMS?

Is SHC or HIMS more profitable?

Do institutionals & insiders hold more shares of SHC or HIMS?

Does the media favor SHC or HIMS?

Do analysts rate SHC or HIMS?

Summary

How does Sotera Health compare to PACS Group?

Does the media favor PACS or SHC?

Do institutionals and insiders have more ownership in PACS or SHC?

Which has higher valuation & earnings, PACS or SHC?

Do analysts prefer PACS or SHC?

Is PACS or SHC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools